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INTRODUCTION
Hyperglycemia is a common finding in critically ill
patients. Hyperglycemia, during critical illness, results
from a stress response that is modulated by the
hypothalamic-pituitary-adrenal axis, the autonomic
nervous system and the cytokines. Recent studies have
shown that hyperglycemia in non-diabetic population
has been associated with increased risk of mortality,
increased length of hospital stay and increased risk of
infections.1
The association between stress and hyperglycemia was
first described in the 19th century by Claude Bernard.2
After Bernard's pioneering study, different terms such as
stress diabetes, traumatic diabetes, diabetes of injury
and critical illness hyperglycemia were used to describe
the correlation between hyperglycemia and stress.3 All
such studies revealed that stress had increased the
release of counter regulatory hormones like glucagon,
epinephrine, cortisol and growth hormone. These
hormones, as a result, increase hepatic glucose
production and decrease peripheral glucose uptake.4
Deleterious effects of hyperglycemia include free radical
formation and abnormalities in white cell function like
granulocyte adhesion defects, chemotaxis, phagocytosis,
and superoxide formation. Hyperglycemia also impairs
complement activity leading to a greater risk of infectious
complications and affects the fluid balance by causing
glycosuria and osmotic diuresis resulting in hypo-
voleamia, electrolyte abnormalities and hyperosmolar
non-ketotic coma. It also increases catabolism in
skeletal muscles.
Studies in adults, using insulin to treat hyperglycemia
and normalize blood glucose levels in large randomized
controlled trials, have shown reduction in ICU mortality
as a result of better glycemic control.5 Moreover,
glycemic control is used in many adult ICU, however, it
is still to be evaluated and implemented for the
paediatric population. For purpose of the present
research, the definition of hyperglycemia is based on the
study conducted by Srinavasan et al.6 This study
showed that non-survivors had more intense
hyperglycemia during the first 48 hours as well as a
longer duration of hyperglycemia. Furthermore, blood
glucose level in hyperglycemic range was occurred in
86% of the patients during their PICU stay and
associated with a 6-fold increase in mortality risk in the
study population. An appropriate management of
hyperglycemia may lead to an improved outcome in the
future.7
The purpose of conducting this study was to find out the
frequency of hyperglycemia in the PICU so that it may
help in formulating recommendations.
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ABSTRACT
Objective: To determine the frequency of hyperglycemia in critically ill children admitted in PICU of a tertiary care hospital
of Karachi and to compare the mortality of critically ill children with and without hyperglycemia.
Study Design: Cross-sectional study.
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Karachi, from November 2011 to April 2012.
Methodology: One hundred fifty critically ill children admitted to PICU were included. Patients who had fasting blood
sugar levels more than 126 mg/dl within 48 hours of admission were included in the hyperglycemic group. The normo-
glycemic and hyperglycemic groups were followed till 10 days to determine the mortality associated with hyperglycemia.
Results: Out of 150 patients, 82 (54.7%) had hyperglycemia. Mortality rate was 48.7% (n=73/150). However, mortality
rate was significantly high 57.3% (n=47) in hyperglycemic patients than non-hyperglycemic patients (p=0.019).
Conclusion: The presence of stress-induced hyperglycemia in critically ill patients is a well established marker of poor
outcome, and a very high mortality rate. Normoglycemia was associated with favorable outcomes in terms of hospital stay
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METHODOLOGY
It was a cross-sectional study conducted from
November 2011 to April 2012 in Paediatric Intensive
Care Unit (PICU) of National Institute of Child Health,
Karachi. The estimated sample size was of 150 patients
of either gender, aged from 1 month to 14 years of age,
who were admitted for the Paediatric ICU. Patients were
enrolled by non-probability sampling. All those patients
who were admitted in PICU for at least 48 hours and
having fasting blood sugar levels more than 126 mg/dl
were included in the hyperglycemic group while those
having blood sugar levels less than 126 mg/dl were
followed in the normoglycemic group.8 Blood sugar
levels were checked at admission and then twice daily
for 48 hours by glucometer. The results were regularly
calibrated and rechecked from laboratory. Both the
groups were followed for 10 days for outcomes like
mortality, shift out to step down or discharged. The
severity of illness was assessed using Paediartic Risk of
Mortality score (PRISM III) obtained from the PICU data
sheet. A low score (< 10) is associated with greater
chances of survival and higher (> 80) score associated
with increased mortality.
Exclusion criteria included diabetic children, hepatic
failure, renal failure requiring dialysis and those having
glucose infusion rate more than six, or patients on
steroids. Data analysis was done using SPSS version
16. Categorical variables like gender, hyperglycemia,
PRISM scores, mortality and shift to step down were
computed in frequency and percentages. Continuous
variables like age, weight, days on mechanical
ventilation were estimated in mean and standard
deviations. Comparison of mortality between hyper-
glycemic and normoglycemic groups were done using
chi-square test. The results were considered statistically
significant when p < 0.05.
RESULTS
A total of 150 patients were included in this study. Most
of the patients were below 3 years of age. Their age,
weight, PRISM score and random blood sugar are
presented in Table I. Out of the 150 cases, 56.7% (n=85)
were male and 43.3% (n=65) were female children. Mild
(PRISM score < 10) was seen in 58% (n=87) cases and
42% (63) were moderate (PRISM score 11 to 79). There
were 37.3% children on ventilation and the average stay
on ventilation was 3.27 ±1.45 days.
Frequency of hyperglycemia in critically ill children was
observed in 82 patients (54.7%). Overall mortality rate
was 48.7% (n=73/150). However, it was significantly
high in hyperglycemic patients than non-hyperglycemic
patients – 57.3% (47/82) vs. 38.2% (26/68) p=0.019).
Age was not significantly associated with hyperglycemia
(p=0.27, Table II). Mortality rate was significantly high in
male patients with hyperglycemia (n=85, p=0.002) than
females (n = 65, p=0.93). Mortality was significantly high
in 10.1 - 15 kg children with hyperglycemia (p=0.02,
Table III). While high PRISM score were significantly
associated with hyperglycemia (n=44/63, p=0.001).
DISCUSSION
Hyperglycemia occurs frequently among critically ill
patients, with prevalence rate reported from 3% to 71%.9
However, there has not been a census statement on the
cut-off value to define significant hyperglycemia.
Different studies have used different values and thus
have reported separate prevalence rates. Studies
revealed a significant association between hyper-
glycemia and increased morbidity and mortality rates
among adult patients, both diabetic and non-diabetic, in
the ICU. In particular, hyperglycemia has been shown to
be a risk factor for poor outcomes in a variety of clinical
settings, including trauma,10 cardiac,11 surgical, head
injury and stroke. Moreover, controlling hyperglycemia
greatly improves the risk of morbidity and death among
such critically ill adult patients.
The sample recruited 150 children which included
predominantly boys (56.7%). Some 54.7% (n=82) of
critically ill children had hyperglycemia. The mortality
rate was also high 57.3% in this group. Further, mortality
of critically ill children with hyperglycemia was
statistically significant (p=0.019). Hyperglycemia, seen
more in boys, could be explained because we had more
male patients than females, as no studies have shown
any gender association of hyperglycemia so far. We also
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Table I: Descriptive statistics of characteristics of patients.
Variables 95%CI Median (IQR) Max-Min
Age (months) 28.95 - 40.83 24 (38) 147 - 1
Weight (kg) 9.38 - 11.47 9 (7) 35 - 2
PRISM III score 8.39 - 10.62 9 (12) 27 - 0
in first 24 hours
Blood glucose 156.78 - 194.65 145 (97) 650 - 22
level (mg/dl)
Table II: Comparing mortality of critically ill children with and without hyper-
glycemia with respect to age.
Age Alive Hyperglycemia Dead Hyperglycemia p-value
In months Yes No Yes No
1 - 12 13 9 22 8 0.37
13 - 36 13 22 12 11 0.29
37 - 60 3 3 5 3 0.99
61 - 144 6 8 8 4 0.27
Table III: Comparing mortality of critically ill children with and without
hyperglycemia with respect to weight.
Weight Alive Hyperglycemia Dead Hyperglycemia p-value
Yes No Yes No
< 5 kg 4 3 18 10 1.00
5.1 <10 kg 20 21 12 9 0.59
10.1 <15 kg 4 12 8 3 0.02
15.1 < 20 kg 6 5 7 2 0.37
> 20 kg 1 1 2 2 0.99
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found that frequency of hyperglycemia in critically ill
patients in respect to age and gender was non-
significant but severity of illness was significant. In
contrast, the study done by Srinivasan et al.12 who had
also inducted a total of 150 patients, having the same
criteria of > 126 mg/dl to define hyperglycemia, found
86% of critically ill children having hyperglycemia. He
had also showed that duration and intensity of
hyperglycemia was higher in non-survivors.
In a prospective randomized study, Van den Berghe
et al.13 reported on 1548 patients admitted to an adult
surgical ICU that during the admission, intensive
treatment with intravenously administered insulin to
control hyperglycemia (target range: 80-110 mg/dl) for
both diabetic and non-diabetic patients reduced the risk
of death in the ICU by 42%, the overall in-hospital
mortality rate by 34%, the sepsis rate by 46%, the acute
renal failure rate by 41%, and the median number of red
blood cell transfusions by 50%. With less-stringent
criteria for glycemic control (target range: 80 - 140
mg/dl), Krinsley also reported that control of hyper-
glycemia greatly improved morbidity and mortality risks
among critically ill adult patients.14 That study, in
contrast to the predominantly postoperative, cardio-
thoracic, surgical population in the study by Van den
Berghe et al., was a historical control trial that included
both medical and surgical patients.15 Van den Berghe et
al. reported the results of a similarly designed,
prospective, randomized study focusing on the effects of
glycemic control (target range: 80 - 110 mg/dl) among
medical, rather than surgical ICU patients. Unlike the
surgical ICU study, tight glycemic control did not reduce
the overall in-hospital mortality rate significantly. The
mortality rate was reduced among patients with ICU
admissions of >3 days. However, there was also a
significant reduction in the morbidity rate, regardless of
the number of days in the ICU. Less is known about the
incidence of hyperglycemia and its effects in the PICU.
Hyperglycemia is an important negative prognostic
factor and an indication of poor neurologic long-term
outcomes among paediatric patients with traumatic head
injuries.16 Among infants, diagnosed as having
necrotizing enterocolitis, hyperglycemia is common and
is associated with longer length of stay (LOS) and
increased rate of late death in the NICU.17 In a study
conducted by Jennifer et al., glucose control protocol
was used by using insulin therapy, achieved
normoglycemia and severe hypoglycemia did not
occur.18 On the contrary, a study conducted in PICU of
Brazil and in Cambridge, UK19 has shown that
normoglycemia is difficult to achieve. it is evident that
glycemic control is associated with increased incidence
of hypoglycemia and use of insulin is not without risk.20
The presence of stress-induced hyperglycemia in
critically ill patients, especially in those without evidence
of antecedent diabetes, is a well-established marker of
poor outcomes.21 Similarly, this study in children found
that 54.7% of critically ill children have hyperglycemia.
Further, mortality of critically ill children with and without
hyperglycemia was statistically significant. Two large
single-center studies, comparing the standard strategy
of permissive hyperglycemia to use intravenous insulin
to achieve a blood glucose between 80 and 110 mg/dl
(intensive insulin therapy), demonstrated overall clinical
benefit with the intensive insulin therapy. However, more
recent studies of insulin therapy in critically ill patients
have yielded conflicting results.22 In addition, a growing
awareness of the potential risk of hypoglycemia, which
can occur more frequently when using intravenous
insulin therapy, has raised concerns over the best way to
control glucose. Despite this, reverting back to allowing
hyperglycemia to continue unchecked, is unlikely to be
the correct approach either.
The main weakness of the study was use of cross-
sectional study design, as the cross-sectional study is
unable to comment on the causative association
between predictor and outcome. The selection of non-
probability sampling limits generalizability of the study
results and findings. Although study sample size was
scientifically calculated, the selection of an
epidemiological study warrants a large sample size to
provide true estimation of frequency and prevalence.
There are many strengths of this study. First, the simple
and single objective determination based on single
outcome and complete, simple, well defined exposure
and outcome variables in measureable terms, reduces
and controls bias and confounders. The scientific apriori
calculation of sample size provides rigor in our sample.
The stringent inclusion and exclusion criteria and
stratification at the level of analysis not only limit the bias
and confounders but also control the effect modification
in the study. These strengths also increase the
generalizability of these findings and worthiness of the
study.
CONCLUSION
A high proportion of severely or critically ill children not
only had hyperglycemia but also a very high mortality
rate as compared to normoglycemic children. The
authors emphasize the need for blood glucose
monitoring in all patients admitted in intensive care units.
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